title: Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues.
abstract: Although altered homeostatic regulation, including disturbance of 24-h rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erbalpha, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligodeoxynucleotide, the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erbalpha, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.
authors.affiliation: Division of Clinical Pharmacy, Department of Biochemistry, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
authors.forename: Satoru
authors.initials: S
authors.lastname: Koyanagi
authors.forename: Sumako
authors.initials: S
authors.lastname: Okazawa
authors.forename: Yukako
authors.initials: Y
authors.lastname: Kuramoto
authors.forename: Kentarou
authors.initials: K
authors.lastname: Ushijima
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimeno
authors.forename: Shinji
authors.initials: S
authors.lastname: Soeda
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Okamura
authors.forename: Shigehiro
authors.initials: S
authors.lastname: Ohdo
mesh_terms: D056930:ARNTL Transcription Factors; D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000187:drug effects / Q000235:genetics; D018797:Cell Cycle Proteins; D002478:Cells, Cultured; D002940:Circadian Rhythm / Q000187:drug effects* / Q000235:genetics*; D004334:Drug Administration Schedule; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000502:physiology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology; D009687:Nuclear Proteins / Q000187:drug effects / Q000235:genetics; D056950:Period Circadian Proteins; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D036401:Toxicity Tests, Chronic; D014157:Transcription Factors / Q000187:drug effects / Q000235:genetics
chemical_list: D056930:ARNTL Transcription Factors; D051792:Basic Helix-Loop-Helix Proteins; D018797:Cell Cycle Proteins; D009687:Nuclear Proteins; D056950:Period Circadian Proteins; D011239:Prednisolone; D014157:Transcription Factors; C538960:BMAL1 protein, human; C538961:Bmal1 protein, mouse; C539022:PER1 protein, human; C421902:PER2 protein, human; C539023:Per1 protein, mouse; C513312:Per2 protein, mouse